Results 71 to 80 of about 38,260 (246)
The Kaohsiung Journal of Medical Sciences, EarlyView.ABSTRACT Hemodialysis (HD) patients are at higher risk of severe COVID‐19 and may exhibit suboptimal vaccine responses. This study evaluates the factors influencing vaccine‐induced immunity in HD patients following the second dose of the Vaxzevria. A total of 276 HD patients and 126 controls were included. Antibody responses were assessed using binding
Chia‐Wei Chang +9 more
wiley +1 more source
Omission of dexamethasone in prophylaxis for highly emetogenic chemotherapy in patients with breast cancer [PDF]
Einstein (São Paulo)Objective Chemotherapy-induced nausea and vomiting are highly prevalent adverse events that can lead to poor treatment adherence and a decreased quality of life.
Camilla Vieira de Rebouças +4 more
doaj +1 more source
Impact of Co‐Morbid Immunocompromise in HPV‐Associated Oropharyngeal Squamous Cell Carcinoma
The Laryngoscope, EarlyView.Among patients with surgically resected Human Papillomavirus positive (HPV+) oropharyngeal squamous cell carcinoma (OPSCC), immunocompromised patients had significantly worse overall survival compared to the non‐compromised group; however, these exploratory findings should be interpreted cautiously.
Maxwell L. Weng +7 more
wiley +1 more source
Antiemetic therapy options for chemotherapy-induced nausea and vomiting in breast cancer patients [PDF]
, 2011 Vicky TC Chan, Winnie YeoDepartment of Clinical Oncology, Faculty of Medicine, Chinese University of Hong Kong, Hong Kong SAR, ChinaAbstract: Chemotherapy-induced nausea and vomiting (CINV) continues to be one of the most distressing side effects of ...
Chan VTC, Yeo W
core
Pediatric Investigation, EarlyView.Pediatric nasal skull base tumors present diagnostic and therapeutic challenges due to their deep location, nonspecific symptoms, and the narrow nasal cavity in children. Although artificial intelligence (AI) and digital medicine have advanced early diagnosis, multidisciplinary treatment, and prognosis, their application in these rare tumors remains ...
Xiuping Wu +5 more
wiley +1 more source
Chemotherapy-induced Nausea and Vomiting
Oncology & Hematology Review (US), 2009 Nausea and vomiting are commonly observed and feared side effects of chemotherapy. Understanding of the physiological mechanisms of chemotherapy-induced nausea and vomiting (CINV) has led to the development of several classes of anti-emetic, including substance P antagonists, serotonin antagonists, and dopamine antagonists.
Ursula A Matulonis, Nicole S Nevadunsky
openaire +1 more source
Management of chemotherapy-induced nausea and vomiting by risk profile: role of netupitant/palonosetron [PDF]
, 2016 Vito Lorusso National Cancer Research Centre, Istituto Tumori Giovanni Paolo II, Bari, Italy Abstract: As recommended by most recent antiemetic guidelines, the optimal prophylaxis of chemotherapy-induced nausea and vomiting (CINV) requires the ...
Lorusso V
core +1 more source
Cancer Management and Research, 2012 S Michael Roberts, Dmitri S Bezinover, Piotr K JanickiDepartment of Anesthesiology, Penn State College of Medicine, Penn State Milton S Hershey Medical Center, Hershey, PA, USAAbstract: Chemotherapy-induced nausea and vomiting and postoperative nausea ...
Janicki PK, Bezinover DS, Roberts SM
doaj
Precision Medical Sciences, EarlyView.The nanoparticle polymeric micellar paclitaxel plus nedaplatin regimen demonstrates superior efficacy and tolerable toxicities compared to the paclitaxel–nedaplatin combination as a first‐line treatment for advanced esophageal squamous cell carcinoma.
Yu‐Qing Cao +7 more
wiley +1 more source
Palonosetron for the prevention of chemotherapy-induced nausea and vomiting: approval and efficacy [PDF]
, 2009 Rudolph M NavariIndiana University School of Medicine South Bend, South Bend, IN USAAbstract: Chemotherapy-induced nausea and vomiting (CINV) is associated with a significant deterioration in quality of life.
Rudolph M Navari
core